| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/31/2008 | WO2008063867A3 Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| 07/31/2008 | WO2008008493A8 Alkyne-substituted pyridone compounds and methods of use |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182994 Crystallization from solvent; removal of impurities |
| 07/31/2008 | US20080182901 Crystalline acid of lipoxin A4 analogs and method of making |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182874 e.g. 1-[6-Chloro-5-[(tricyclo[3.3.1.13,7]dec-1-ylacetyl)amino]-2-quinolinyl]-4piperidinecarboxylic acid; adamantyl-containing purinergic receptor P2X7 antagonists; antiinflammatory agent, immune or cardiovascular diseases; asthma, chronic obstructive pulmonary disease, rheumatoid arthritis |
| 07/31/2008 | US20080182789 Method of treating pulmonary fibrosis |
| 07/31/2008 | US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell |
| 07/31/2008 | US20080182236 Within human chromosome 7p15-p14; GPRA polypeptides, nucleic acids, host cells, primers and probes; transgenic animal models; anticarcinogenic agents; chronic obstructive pulmonary disorder; diagnosis; analyzing allelic variation in the locus and GPRA gene |
| 07/31/2008 | US20080181966 Modafinil pharmaceutical compositions |
| 07/31/2008 | US20080181951 Treatment of humans with colloidal silver composition |
| 07/31/2008 | US20080181909 Chimeric immunomodulatory compounds and methods of using the same |
| 07/30/2008 | EP1950307A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 07/30/2008 | EP1950302A2 Streptococcus antigens |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1949892A1 Aerosol for inhalation comprising a tiotropium salt |
| 07/30/2008 | EP1948630A2 Novel compounds |
| 07/30/2008 | EP1948596A2 Soft anticholinergic esters |
| 07/30/2008 | EP1948186A1 Aerosolformulation for inhalation |
| 07/30/2008 | EP1948176A1 Diaryl ureas for treating pulmonary hypertension |
| 07/30/2008 | EP1948170A1 Diaryl urea for treating pulmonary hypertension |
| 07/30/2008 | EP1948167A1 Compositions of phosphodiesterase type iv inhibitors |
| 07/30/2008 | EP1948164A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 07/30/2008 | EP1948147A2 Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 07/30/2008 | EP1948146A2 Novel multi-cyclic compounds and their use |
| 07/30/2008 | EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | CN101233107A Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases |
| 07/30/2008 | CN101230099A Streptococcus pneumoniae proteins and nucleic acid molecules |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229363A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 07/30/2008 | CN101229358A Chinese traditional medicine compounds for treating pneumonia, emphysema and preparing method thereof |
| 07/30/2008 | CN101229343A Chinese traditional medicine for treating pulmonary tuberculosis |
| 07/30/2008 | CN101229338A Heat cough oral liquid |
| 07/30/2008 | CN101229337A Chinese traditional medicine for treating bronchitis and bronchial asthma |
| 07/30/2008 | CN101229321A Chinese traditional medicine granule for treating chronic pharyngitis |
| 07/30/2008 | CN101229319A Cold cough oral liquid |
| 07/30/2008 | CN101229318A Ginseng gajiesan oral preparation and preparing method thereof |
| 07/30/2008 | CN101229317A Removing heat-phlegm, relieving cough, and moistening lung medicine and preparing method thereof |
| 07/30/2008 | CN101229315A Method for producing salty rhizoma anemarrhenae |
| 07/30/2008 | CN101229290A Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof |
| 07/30/2008 | CN101229283A Zhongganling capsule and preparing method thereof |
| 07/30/2008 | CN101229267A Medicine compounds for pulmonary and rheumatic heart disease and preparing method thereof |
| 07/30/2008 | CN101229232A Chinese traditional medicine preparation for curing pulmonary fibrosis |
| 07/30/2008 | CN101229199A Integrative extract method of multi-active ingredient in cordyceps militaris mycelium |
| 07/30/2008 | CN101229155A Medicine compounds for treating pharyngitis sicca |
| 07/30/2008 | CN101228968A Cigarette additive decreasing smoke gas harm |
| 07/30/2008 | CN100406456C Process for preparing scopine esters |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406435C 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/30/2008 | CN100406056C Nutritional oral liquid |
| 07/30/2008 | CN100406024C Preparing method for exogenous nitric oxide |
| 07/30/2008 | CN100406009C Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/30/2008 | CN100406003C Dripping pills of abastard speedwell and its preparation process |
| 07/30/2008 | CN100405920C Dried orange peel health-care tea |
| 07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405223 Treating allergic and inflammatory conditions |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404953 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2461921C Composition of hypochlorous acid and its applications |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2368413C Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2201377C Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/29/2008 | CA2192543C Interleukin-5 specific recombinant antibodies |
| 07/24/2008 | WO2008089260A2 Combined administration of benzonatate and guaifenesin |
| 07/24/2008 | WO2008088727A2 Endothelin receptor antagonists |
| 07/24/2008 | WO2008088617A1 Treatment of copd |
| 07/24/2008 | WO2008087437A1 Treatment of corticoid-resistant asthma or copd with p38 map kinase inhibit (eg. sb2035809) |
| 07/24/2008 | WO2008043825A3 Pharmaceutical anti-infective composition for inhalation. |
| 07/24/2008 | WO2008021375A3 Modulators of muscarinic receptors |
| 07/24/2008 | WO2004071573A3 Hypoxia induced mitogenic factor |